摘要
甲状腺乳头状癌高细胞亚型最初描述于1976年,一直被认为是甲状腺乳头状癌中预后较差的一种亚型.本文描述了此亚型的临床病理特征、分子生物学相关性、治疗及其预后.目的在于提醒人们重视此亚型,并对其做更深入的研究,找出针对这种亚型的有效靶向疗法.
出处
《国际耳鼻咽喉头颈外科杂志》
2013年第1期30-33,共4页
International Journal of Otolaryngology-Head and Neck Surgery
参考文献30
-
1Hotomi M,Sugitani I,Toda K,et al.A novel definition of extrathyroidal invasion for patients with papillary thyroid carcinoma for predicting prognosis.World J Surg,2012,36(6):1231-1240.
-
2Hawk WA,Hazard JB.The many appearances of papillary carcinoma of the thyroid.Cleveland Clinic Quarterly,1976,43(4):207-216.
-
3Morris LG,Shaha AR,Tuttle RM,et al.Tall-cell variant of papillary thyroid carcinoma:a matched-pair analysis of survival.Thyroid,2010,20 (2):153-158.
-
4Silver CE,Owen RP,Rodrigo JP,et al.Aggressive variants of papillary thyroid carcinoma.Head Neck,2011,33 (7):1052-1059.
-
5Ghossein RA,Livolsi VA.Papillary thyroid carcinoma tall cell variant.Thyroid,2008,18 (11):1179-1181.
-
6Lloyd RV,Buehler D,Khanafshar E.Papillary Thyroid Carcinoma Variants.Head Neck Pathol,2011,5 (1):51-56.
-
7Urano M,Kiriyama Y,Takakuwa Y,et al.Tall cell variant of papillary thyroid carcinoma:its characteristic features demonstrated by fine-needle aspiration cytology and immunohistochemical study.Diagn Cytopathol,2009,37(10):732-737.
-
8Michels JJ,Jacques M,Henry-Amar M,et al.Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma.HumPathol,2007,38 (2):212-219.
-
9Ghossein RA,Leboeuf R,Patel KN,et al.Tall cell variant of papillary thyroid carcinoma without extrathyroid extension:biologic behavior and clinical implications.Thyroid,2007,17(7):655-661.
-
10Lin JD,Hsueh C,Huang BY.Papillary thyroid carcinoma with different histological patterns.长庚医学杂志,2011,34 (1):23-34.
二级参考文献28
-
1Jossart GH, Clark OH. Well - differentiated thyroid cancer [ J ]. Curr Probl Surg, 1994,31:933 - 1012.
-
2Carling T, Udelsman R. Thyroid tumors[A]. DeVita VT Jr, Hellman S,Rosenberg SA. Cancer:Principles and practice of Oncology [ M]. Philadelphia: Lippincott Williams and Wilkins, 2005 : 1502-1519.
-
3Langhans T. Uber die epithelialen formen der malignen struma[ J]. Virehows Arch Pathol Anat, 1907,189:69 - 188.
-
4Carcangiu ML, Zampi G, Rosai J. Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans wuchernde Strumagi J]. Am J Surg Pathol,1984,8:655 -668.
-
5Pilotti S, Collini P, Mariani L, et al. Insular carcinoma: adistinct de novo entity among follicular carcinomas of the thyroid gland [ J ]. Am J Surg Pathol, 1997,21 : 1466 - 1473.
-
6Ashfaq R, Vuitch F, Delgado R, et al. Papillary and follicular thyroid carcinomas with an insular component[ J]. Cancer, 1994,73: 4116 -4123.
-
7Sywak M, Pasieka J, Ogilvie T. A review of thyroid cancer with intermediate differentiation [ J ]. J Surg Oncol,2004,86:44 - 54.
-
8Guiter GE, Auger M, Ali SZ, et al. Cytopathology of insular carcinoma of the thyroid [ J ]. Cancer, 1999,87 : 196 - 202.
-
9Zakowski MF, Schlesinger K, Mizrachi HH. Cytologic features of poorly differentiated "Insular" carcinoma of the thyroid. A case report[ J]. Acta Cytol, 1992,36:523 - 526.
-
10Tobias C. Special variants of differentiated thyroid cancer: does it alter the extent of surgery versus well - differentiated thyroid cancer[J] ? World J Surgery,2007,31:916 -923.
共引文献4
-
1方铣华,葛明华,罗娟.甲状腺低分化癌(岛状癌)的病理诊断[J].肿瘤学杂志,2011,17(8):625-629. 被引量:3
-
2沈晓卉,薛松,丁家增,陈海珍,陈曦,李宏为.同期双侧侧颈淋巴结清扫术在甲状腺癌治疗中的应用[J].外科理论与实践,2014,19(6):525-528. 被引量:3
-
3孙振宇,武林枫,王刚.甲状腺乳头状癌淋巴结转移相关危险因素研究进展[J].医学综述,2018,24(16):3177-3181. 被引量:5
-
4董方,薛金才,王云生,刘勤江.甲状腺癌外照射放射治疗的变迁[J].国际肿瘤学杂志,2019,46(11):641-648. 被引量:1
同被引文献2
-
1无,高明,葛明华,嵇庆海,徐震纲,陆汉魁,程若川,关海霞.甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版)[J].中国肿瘤临床,2016,43(10):405-411. 被引量:378
-
2舒启沛,方可敬,郭燕丽.弥漫硬化型甲状腺乳头状癌的影像学研究进展[J].临床超声医学杂志,2019,21(10):766-768. 被引量:3
二级引证文献5
-
1王刚.超声检查对甲状腺弥漫性病变合并结节的诊断有效性研究[J].实用医技杂志,2022,29(4):351-353.
-
2朱琳,严继萍,王金萍,刘莎.基于临床、超声及基因特征列线图预测甲状腺乳头状癌侵袭性[J].中国介入影像与治疗学,2022,19(6):356-360. 被引量:4
-
3韩娜,李娇,卢承慧,王聪聪,刘新峰,王国强,王增华,张莹莹,司增梅,赵子龙,李凤岐,王叙馥.高侵袭性病理亚型甲状腺乳头状癌患者初始治疗疗效影响因素分析[J].中华转移性肿瘤杂志,2023,6(3):223-228.
-
4胥桐,梁羽,宋军,黄富洪,张静,李璇,范尔兮.基于SEER数据库构建高危PTMC的诊断模型与验证[J].重庆医科大学学报,2023,48(12):1418-1424.
-
5刘延泽,刘嘉琦,李良.BRAF V600E在甲状腺乳头状癌临床应用性中的研究进展[J].临床医学进展,2022,12(9):8499-8507. 被引量:1
-
1戴毅,杨仁池.神经胶质瘤治疗新策略[J].国外医学(肿瘤学分册),2004,31(7):514-517.
-
2杨铁耀,胡晋.癌细胞膜相关抗原与靶向治疗[J].沈阳药学院学报,1992,9(3):224-228.
-
3蒲军,彭秀兰.使用全脑放疗联合厄洛替尼靶向疗法治疗非小细胞肺癌脑转移的效果观察[J].当代医药论丛,2016,14(17):3-5. 被引量:6
-
4陈文生.肝动脉介入联合靶向疗法对结肠癌肝转移的治疗价值分析[J].中国卫生标准管理,2015,6(31):50-51.
-
5郑伟华.晚期大肠癌靶向疗法的优势[J].广东医学,2006,27(12):1911-1913. 被引量:2
-
6郑伟华.晚期大肠癌靶向疗法的优势[J].中国健康月刊,2007(5):38-41.
-
7易宣洪,王静.化疗联合吉非替尼小分子靶向治疗50例肺癌的疗效及安全性[J].肿瘤学杂志,2017,23(4):345-348. 被引量:8
-
8李明峰.如何应对肺癌靶向治疗的副作用[J].求医问药,2011(4):24-25.
-
9丰水强.靶向疗法联合转移瘤切除治疗进行性肾细胞癌[J].现代泌尿生殖肿瘤杂志,2011,3(5):291-291.
-
10孙晓江,许亚萍(综述),毛伟敏(审校).表皮生长因子受体靶向抑制剂在食管癌中的应用[J].国际肿瘤学杂志,2010,37(12):922-925. 被引量:4